drugset
drugset / Trial / NCT05439876

Getting SMART for Pediatric Epilepsy

NCT05439876 ↗

Phase 2/3 Completed 147 enrolled National Taiwan University Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effect of melatonin for improving sleep in pediatric epilepsy.

Timeline

Start
2022-07-18
Primary completion
2025-01-03
Completion
2025-01-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 2 mg —

Indications

epilepsy